[pending] UDENYCA (PEGFILGRASTIM-CBQV)
Pending LLM rewrite. Source: FDA_DRUG D-0353-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
The recalled product
- Product
- UDENYCA (PEGFILGRASTIM-CBQV)
- Brand
- UDENYCA
- Manufacturer
- McKesson
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Subset of Lot 2199821
- Expires: 05/31/2027 Specific Serial Numbers being Recalled: 160R694TT06X
- 1C74A686RPPG
- 1W6A2M777N3V
- 20825394KR8P
- 242E2RK3EA92
- 2DG49VH89EPG
- 2WEA2ADK1P4H
- 3KR2TVAG3VDH
- 42M0V0G9PM84
- 46E9XKDPTH1R
- 4AM12WEAE48H
- 4FGHR096DMNV
- 4MWGWM991XNA
- 4NEW8XD9DNM2
- 4Y2PYDFN9YA1
- 61EPX42R4K2A
- 63FN9VW5CAV7
- 69TG160DW2CV
- 69XFP3TMTP7X
UPCs (1)
- 0369448025632
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27